GNTA
Genenta Science S.p.A.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Last price
1.24
▲ 0.05 (4.20%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
1.20
Prev close
1.19
Day high
1.29
Day low
1.22
Volume
23.78K
Market cap
$60.75M
P/E (TTM)
—
52W range
0.55 – 10.00
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
10.02M
Total on file
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
-3.08%
-1.7%
1M
-23.64%
-27.4%
3M
+113.56%
+110.5%
6M
+26.00%
+14.9%
YTD
-15.44%
-27.7%
1Y
-64.41%
-84.4%
3Y
-76.45%
-150.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$60.75M
Enterprise value$9.18M
Revenue (TTM)—
Gross profit—
EBITDA$-6.58M
Net income$-6.53M
EPS (TTM)$-0.39
Free cash flow$-3.10M
Total cash$28.15M
Total debt$7.60M
Book value / share$1.08
Shares outstanding48.22M
Float13.87M
Short % of float0.32%
Dividend yield—
Beta (5Y)0.77
Short interest
Shares short
146.51K
Prior 166.41K
Change vs prior
-12.0%
Shorts covering
% of float
0.32%
Normal
% of shares out
0.30%
Against total outstanding
Days to cover
1.6
Liquid
Float
13.87M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Valuation & profitability ratios
Trailing P/E—
Forward P/E-1.94
PEG ratio—
Price / sales—
Price / book1.17
EV / revenue—
EV / EBITDA-1.40
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity-38.03%
Return on assets-17.67%
Debt / equity34.81
Current ratio14.16
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | — |
| Research & development | $2.70M | $4.81M | $6.47M | $5.34M | -43.9% |
| Selling, general & admin | $3.90M | $4.95M | $5.26M | $5.71M | -21.1% |
| Total operating expense | $6.60M | $9.76M | $11.73M | $11.04M | -32.4% |
| Operating income | -$6.60M | -$9.76M | -$11.73M | -$11.04M | +32.4% |
| Net interest income | $608.51K | $81.14K | $309.25K | $36.98K | +649.9% |
| Pre-tax income | -$6.53M | -$8.91M | -$11.65M | -$8.48M | +26.7% |
| Tax provision | $0 | $0 | $0 | $0 | — |
| Net income | -$6.53M | -$8.91M | -$11.65M | -$8.48M | +26.7% |
| Net income to common | -$6.53M | -$8.91M | -$11.65M | -$8.48M | +26.7% |
| Basic EPS | -0.33 | -0.49 | -0.64 | -0.47 | +32.7% |
| Diluted EPS | -0.33 | -0.49 | -0.64 | -0.47 | +32.7% |
| EBIT | -$6.60M | -$9.76M | -$11.73M | -$11.04M | +32.4% |
| EBITDA | -$6.58M | -$9.72M | -$11.69M | -$11.04M | +32.3% |
| Basic shares | 19.71M | 18.27M | 18.22M | 18.22M | +7.9% |
| Diluted shares | 19.71M | 18.27M | 18.22M | 18.22M | +7.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $5.53M | $4.58M | $3.69M | $29.79M | +20.6% |
| Cash & short-term investments | $28.15M | $12.66M | $18.78M | $29.79M | +122.4% |
| Total current assets | $29.98M | $14.47M | $21.26M | $31.72M | +107.1% |
| Property, plant & equipment | $22.46K | $42.92K | $82.98K | $111.64K | -47.7% |
| Total assets | $31.89M | $14.82M | $22.35M | $33.44M | +115.1% |
| Total current liabilities | $2.12M | $2.10M | $1.74M | $2.18M | +0.9% |
| Long-term debt | $7.60M | — | — | — | — |
| Total debt | $7.60M | — | — | — | — |
| Total liabilities | $10.05M | $2.33M | $1.91M | $2.30M | +331.6% |
| Retained earnings | -$62.59M | -$56.06M | -$47.14M | -$35.47M | -11.6% |
| Shareholder equity | $21.84M | $12.50M | $20.43M | $31.14M | +74.8% |
| Working capital | $27.86M | $12.37M | $19.52M | $29.54M | +125.2% |
| Net tangible assets | $21.84M | $12.50M | $20.43M | $31.14M | +74.8% |
| Shares issued | 23.43M | 18.29M | 18.22M | 18.22M | +28.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$6.53M | -$8.91M | -$11.65M | -$8.48M | +26.7% |
| Depreciation & amortisation | $28.08K | $44.52K | $42.45K | $6.14K | -36.9% |
| Stock-based compensation | $1.01M | $847.25K | $739.88K | $722.74K | +19.2% |
| Change in working capital | -$1.58M | $1.72M | -$417.60K | $240.30K | -191.9% |
| Operating cash flow | -$6.87M | -$6.24M | -$11.21M | -$7.42M | -10.1% |
| Capital expenditure | -$7.63K | -$4.47K | -$13.79K | -$27.07K | -70.7% |
| Investing cash flow | -$14.54M | $6.88M | -$14.89M | -$27.07K | -311.3% |
| Financing cash flow | $22.29M | $270.88K | $531 | $0 | +8,127.6% |
| Free cash flow | -$6.88M | -$6.24M | -$11.22M | -$7.45M | -10.1% |
| End cash position | $5.53M | $4.58M | $3.69M | $29.79M | +20.6% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2024-12-31 | YoY |
|---|---|---|---|
| Cash & equivalents | $5.53M | $4.58M | +20.6% |
| Cash & short-term investments | $28.15M | $12.66M | +122.4% |
| Total current assets | $29.98M | $14.47M | +107.1% |
| Property, plant & equipment | $22.46K | $42.92K | -47.7% |
| Total assets | $31.89M | $14.82M | +115.1% |
| Total current liabilities | $2.12M | $2.10M | +0.9% |
| Long-term debt | $7.60M | — | — |
| Total debt | $7.60M | — | — |
| Total liabilities | $10.05M | $2.33M | +331.6% |
| Retained earnings | -$62.59M | -$56.06M | -11.6% |
| Shareholder equity | $21.84M | $12.50M | +74.8% |
| Working capital | $27.86M | $12.37M | +125.2% |
| Net tangible assets | $21.84M | $12.50M | +74.8% |
| Shares issued | 23.43M | 18.29M | +28.1% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders42.47%
Held by institutions4.85%
Institutions holding13
Price targets, consensus spread, insider and institutional ownership.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 2, 24 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| May 13, 24 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Feb 8, 23 | HC Wainwright & Co. | MAINTAINED | — | Buy |
| Jan 5, 23 | EF Hutton | INITIATED | — | Buy |
| Jul 25, 22 | HC Wainwright & Co. | INITIATED | — | Buy |
| Jan 13, 22 | Maxim Group | INITIATED | — | Buy |
Moving averages & technicals
SMA 10
1.26
-1.59% from price
SMA 20
1.33
-5.55% from price
SMA 50
1.54
-18.18% from price
SMA 100
1.21
+2.59% from price
SMA 200
1.27
-0.97% from price
EMA 12
1.28
-2.82% from price
EMA 26
1.36
-8.50% from price
EMA 50
1.38
-10.13% from price
RSI (14)
43.1
Neutral
MACD (12,26,9)
-0.08
Hist -0.01
ATR (14)
0.08
6.40% of price
Realised vol 30D
111.9%
Annualised
Bollinger upper
1.56
20, 2σ
Bollinger lower
1.10
20, 2σ
50 / 200 cross
Golden
1.54 vs 1.27
Trend bias
Below 200
-0.97%
Risk profile
Beta vs SPY
1.67
More volatile than market
Correlation to SPY
0.13
Largely independent
Realised vol 30D
111.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-90.6%
Peak to trough
Max drawdown 5Y
-95.1%
Peak to trough
ATR 14
0.08
6.40% of price
Beta (reported)
0.77
5Y monthly, from filing
SEC filings
Corporate Changes & Voting Matters
6-K · 2026-07-31
Corporate Changes & Voting Matters
6-K · 2026-07-14
Corporate Changes & Voting Matters
6-K · 2026-07-01
Corporate Changes & Voting Matters
6-K · 2026-06-26
Corporate Changes & Voting Matters
6-K · 2026-06-24
Corporate Changes & Voting Matters
6-K · 2026-06-17
Corporate Changes & Voting Matters
6-K · 2026-06-16
Corporate Changes & Voting Matters
6-K · 2026-05-29
Headlines
Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm
GlobeNewswire · 31d ago
Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results
GlobeNewswire · 32d ago
European Equities Traded in the US as American Depositary Receipts Decline Friday
MT Newswires · 36d ago
Top Premarket Gainers
MT Newswires · 83d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.